XM tidak menyediakan perkhidmatan kepada penduduk Amerika Syarikat.
K
K

KBC


Berita

FX steady after ECB rate cut

CEE MARKETS-FX steady after ECB rate cut By Alan Charlish WARSAW, Sept 13 (Reuters) - Central European currencies hovered near recent levels on Friday, as markets pared back bets on further easing from the European Central Bank and weighed inflation data from Poland. The ECB cut interest rates again on Thursday and signalled a "declining path" for borrowing costs in the months ahead.
E
E
E
K
U
U

CZECH CENTRAL BANK: LEAVES COUNTERCYCLICAL CAPITAL BUFFER RATE FOR BANKS AT 1.25%

Czech central bank leaves countercyclical buffer rate unchanged PRAGUE, Sept 12 (Reuters) - The Czech National Bank (CNB) said on Thursday the board decided to leave the countercyclical capital buffer rate applied to banks steady at 1.25% after two previous cuts this year. "This was prompted above all by an assessment of cyclical risks, which remain stable even as the Czech economy gradually shifts to the start of the expansionary phase of the financial cycle," the CNB said in a statement after
K
E

Ackermans & van Haaren up as private banking drives strong H1 performance

BUZZ-Ackermans & van Haaren up as private banking drives strong H1 performance ** Shares in Ackermans & van Haaren ACKB.BR are up 3.2% after the Belgium-listed holding firm posted strong H1 results carried largely by private banking ** KBC Securities highlights the net result before capital gains/losses rose by 38% to 224.2 mln euros ($248.4 mln) "
A
K

Currencies steady as Hungary central bank set to pause after 15 rate cuts

CEE MARKETS-Currencies steady as Hungary central bank set to pause after 15 rate cuts By Boldizsar Gyori BUDAPEST, Aug 27 (Reuters) - Central European currencies were little changed on Tuesday ahead of a Hungarian central bank rate decision likely delivering the first pause in its policy easing after more than a year. Hungary's central bank is expected to pause its easing cycle on Tuesday after 15 consecutive rate cuts beginning in May 2023, cautioned by Hungarian headline inflation HUCPIY=ECI r
E
E
E
K
U
U

Galapagos rises on FDA clearance for phase 1/2 1 study

BUZZ-Galapagos rises on FDA clearance for phase 1/2 ATALANTA-1 study ** Shares in Galapagos GLPG.AS rise 2.7%, paring earlier gains of as much as 4%, after the Belgian biotech company obtained FDA clearance to initiate its ATALANTA-1 study with GLPG5101 in the U.S. ** "We see the FDA clearance as an important milestone for Galapagos' GLPG5101 program," says KBC Securities, adding the company will now be able to start treating patients in the U.S.
G
K

Danske Bank, Lotus Bakeries NV, Vesuvius

EUROPE RESEARCH ROUNDUP-Danske Bank, Lotus Bakeries NV, Vesuvius Aug 13 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Danske Bank, Lotus Bakeries NV and Vesuvius, on Tuesday. HIGHLIGHTS * Abrdn Plc ABDN.L : Morgan Stanley raises target price to 160p from 149p * Danske Bank DANSKE.CO : Morgan Stanley initiates coverage with overweight rating * Lotus Bakeries NV LOTB.BR : Berenberg raises target price to EUR 10,300 from EUR 9,000 *
A
A
A
B
C
D
E
F
H
H
K
L
M
M
N
O
S
S
S
S
S
H
A
S
U

Ashtead Group, Beazley, Entain

EUROPE RESEARCH ROUNDUP-Ashtead Group, Beazley, Entain Aug 9 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Ashtead Group, Beazley and Entain, on Friday. HIGHLIGHTS * Ashtead Group Plc AHT.L : KeyBanc initiates coverage with sector weight rating * Beazley Plc BEZG.L : Berenberg raises target price to 950p from 880p * Entain Plc ENT.L : Deutsche Bank cuts target price to 958p from 1,089p * Rheinmetall AG RHMG.DE : Morgan Stanley up
A
A
A
A
B
B
B
C
C
D
D
E
G
G
H
H
H
I
K
O
B

Euro zone equities "less than stellar" - Pictet AM

LIVE MARKETS-Euro zone equities "less than stellar" - Pictet AM STOXX 600 down 0.9% Volatility above 23 Tech leads fallers Some UK earnings please Wall St futures mixed Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com EURO ZONE EQUITIES "LESS THAN STELLAR" - PICTET AM Pictet Asset Management has downgraded its rating on European equities to neutral from overweight, even though the
B
D
K
S
U
I
E
F
U
G

Banks: a good entry point?

LIVE MARKETS-Banks: a good entry point? STOXX 600 down 0.9% Volatility above 23 Tech leads fallers Some UK earnings please Wall St futures mixed Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com BANKS: A GOOD ENTRY POINT? Just as with tech, dip buyers are also showing up for Europe's battered banking sector, even though there still could be fresh bouts of volatility before things p
B
D
G
K
S
U
I
E
F
U
G

Down (slightly) we go again...

LIVE MARKETS-Down (slightly) we go again... Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com DOWN (SLIGHTLY) WE GO AGAIN... European futures were pointing to a weaker start on Thursday after a late reversal into the red on Wall Street that suggested traders were keen to sell into rallies before markets properly settle, following this month's volatility spike.
D
K
P
S
A
F
U
G

KBC upbeat on interest income as loan demand picks up

UPDATE 3-KBC upbeat on interest income as loan demand picks up Sees 2024 NII of 5.5 bln euros vs 5.3-5.5 bln before Forecasts 4% growth in loan volume in 2024 Q2 net profit 925 mln euros vs forecast 864 mln Adds CEO quote, detail on geographical markets, shares By Matteo Allievi and Leo Marchandon Aug 8 (Reuters) - Belgian bank KBC KBC.BR on Thursday raised its 2024 growth forecasts for lending and net interest income (NII) after they drove stronger than expected second-quarter profits.
K
A

KBC Now Sees Full Year 2024 NII at EUR 5.5 Bln

BRIEF-KBC Now Sees Full Year 2024 NII at EUR 5.5 Bln Aug 8 (Reuters) - Kbc Groep NV KBC.BR : KBC GROUP: SECOND-QUARTER RESULT OF 925 MILLION EUROS H1 2024 NET PROFIT 1.431 BILLION EUROS H1 NET PROFIT BENEFITED FROM A POSITIVE 0.4-BILLION-EURO ONE-OFF GAIN ON SALE OF IRISH LOAN AND DEPOSIT BOOKS Q2 LOAN PORTFOLIO INCREASED BY 2% QUARTER-ON-QUARTER A
K

PostNL rises as Q2 EBIT beat outshines parcel volume miss

BUZZ-PostNL rises as Q2 EBIT beat outshines parcel volume miss ** Shares in PostNL PTNL.AS rise 3.2%, reversing course after dropping around 4.4% at market open, after the Dutch postal operator beat Q2 EBIT expectations ** "The solid performance was driven by a continuation of existing trends, including strong international parcel volume growth, wh
K
P

dsm-firmenich at 14-mth highs as volumes drive Q2 beat

BUZZ-dsm-firmenich at 14-mth highs as volumes drive Q2 beat ** Shares in dsm-firmenich DSFIR.AS rise around 3 %, touching their highest price in 14 months, after the Dutch chemicals maker posted H1 results above market expectations ** dsm-firmenich posts Q2 EBITDA of 513 million euros, 3% ahead of Vara consensus and "marginally ahead of buyside exp
J
K

ASM International shares dip despite Q2 results beating expectations

BUZZ-ASM International shares dip despite Q2 results beating expectations ** Shares in Chip-making equipment supplier ASM International fall around 2% after dropping as much as 4.5% earlier, as its Q2 results beat failed to impress investors ** ASMI raised its guidance after orders beat expectations thanks to AI-related products that outweighed a d
K
N

Czech Central Bank Lending Survey: Demand For Housing Loans Increases

BRIEF-Czech Central Bank Lending Survey: Demand For Housing Loans Increases July 23 (Reuters) - CZECH CENTRAL BANK LENDING SURVEY: BANKS LEFT CREDIT STANDARDS AND THE OVERALL CREDIT CONDITIONS FOR LOANS TO NON-FINANCIAL CORPORATIONS UNCHANGED IN Q2 CZECH CENTRAL BANK LENDING SURVEY: BANKS STILL REGARD THE LEVEL OF DOMESTIC INTEREST RATES AS A FACTO
K
E



Syarat

Aset Popular

Penafian: Entiti XM Group menyediakan perkhidmatan pelaksanaan sahaja dan akses ke Kemudahan Dagangan Atas Talian, yang membolehkan sesorang melihat dan/atau menggunakan kandungan yang ada di dalam atau melalui laman web, tidak bertujuan untuk mengubah atau memperluas, juga tidak mengubah atau mengembangkannya. Akses dan penggunaan tersebut tertakluk kepada: (i) Terma dan Syarat; (ii) Amaran Risiko; dan Penafian Penuh. Oleh itu, kandungan sedemikian disediakan tidak lebih dari sekadar maklumat umum. Terutamanya, perlu diketahui bahawa kandungan Kemudahan Dagangan Atas Talian bukan permintaan, atau tawaran untuk melakukan transaksi dalam pasaran kewangan. Berdagang dalam mana-mana pasaran kewangan melibatkan tahap risiko yang besar terhadap modal anda.

Semua bahan yang diterbitkan di Kemudahan Dagangan Atas Talian kami bertujuan hanya untuk tujuan pendidikan/maklumat dan tidak mengandungi – dan tidak boleh dianggap mengandungi nasihat kewangan, cukai pelaburan atau dagangan dan cadangan, atau rekod harga dagangan kami, atau tawaran, atau permintaan untuk suatu transaksi dalam sebarang instrumen kewangan atau promosi kewangan yang tidak diminta kepada anda.

Sebarang kandungan pihak ketiga serta kandungan yang disediakan oleh XM, seperti pendapat, berita, penyelidikan, analisis, harga, maklumat lain atau pautan ke laman web pihak ketiga yang terdapat dalam laman web ini disediakan berdasarkan "seadanya" sebagai ulasan pasaran umum dan bukanlah nasihat pelaburan. Sesuai dengan apa-apa kandungan yang ditafsir sebagai penyelidikan pelaburan, anda mestilah ambil perhatian dan menerima bahawa kandungan tersebut tidak bertujuan dan tidak sediakan berdasarkan keperluan undang-undang yang direka untuk mempromosikan penyelidikan pelaburan bebas dan oleh itu, ia dianggap sebagai komunikasi pemasaran di bawah peraturan dan undang-undang yang berkaitan. SIla pastikan bahawa anda telah membaca dan memahami Notifikasi mengenai Penyelidikan Pelaburan Bukan Bebas dan Amaran Risiko mengenai maklumat di atas yang boleh diakses di sini.

Amaran Risiko: Modal anda dalam risiko. Produk yang berleveraj mungkin tidak sesuai untuk semua individu. Sila pertimbangkan Pendedahan Risiko kami.